Interaction of novel hybrid compounds with the D3 dopamine receptor: Site-directed mutagenesis and homology modeling studies.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Biochemical Pharmacology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.bcp.2010.08.026PMID 20833147PMCID PMC2991514
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Concentration of receptor and ligand revisited in a modified receptor binding protocol for high-affinity radioligands: [3H]Spiperone binding to D2 and D3 dopamine receptors.

  2010cited by this paper
• Dopamine D2, D3, and D4 selective phenylpiperazines as molecular probes to explore the origins of subtype specific receptor binding.

  2009cited by this paper
• Further structure-activity relationships study of hybrid 7-{[2-(4-phenylpiperazin-1-yl)ethyl]propylamino}-5,6,7,8-tetrahydronaphthalen-2-ol analogues: identification of a high-affinity D3-preferring agonist with potent in vivo activity with long duration of action.

  2008cited by this paper
• On the applicability of GPCR homology models to computer-aided drug discovery: a comparison between in silico and crystal structures of the beta2-adrenergic receptor.

  2008cited by this paper
• Bioisosteric heterocyclic versions of 7-{[2-(4-phenyl-piperazin-1-yl)ethyl]propylamino}-5,6,7,8-tetrahydronaphthalen-2-ol: identification of highly potent and selective agonists for dopamine D3 receptor with potent in vivo activity.

  2008cited by this paper
• Structurally constrained hybrid derivatives containing octahydrobenzo[g or f]quinoline moieties for dopamine D2 and D3 receptors: binding characterization at D2/D3 receptors and elucidation of a pharmacophore model.

  2008cited by this paper
• High-Resolution Crystal Structure of an Engineered Human β2-Adrenergic G Protein–Coupled Receptor

  2007cited by this paper
• Development and application of hybrid structure based method for efficient screening of ligands binding to G-protein coupled receptors

  2007cited by this paper
• High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor.

  2007cited by this paper
• Ab initio computational modeling of long loops in G-protein coupled receptors

  2006cited by this paper
• Synthesis and biological characterization of novel hybrid 7-[[2-(4-phenyl-piperazin-1-yl)-ethyl]-propyl-amino]-5,6,7,8-tetrahydro-naphthalen-2-ol and their heterocyclic bioisosteric analogues for dopamine D2 and D3 receptors.

  2004cited by this paper
• The second extracellular loop of the dopamine D2 receptor lines the binding-site crevice.

  2004cited by this paper
• Molecular modeling of the three-dimensional structure of dopamine 3 (D3) subtype receptor: discovery of novel and potent D3 ligands through a hybrid pharmacophore- and structure-based database searching approach.

  2003cited by this paper
• A novel series of hybrid compounds derived by combining 2-aminotetralin and piperazine fragments: binding activity at D2 and D3 receptors.

  2002cited by this paper
• A Novel Series of Hybrid Compounds Derived by Combining 2‐Aminotetralin and Piperazine Fragments: Binding Activity at D2 and D3 Receptors

  2002cited by this paper
• Conformational change of proteins arising from normal mode calculations.

  2001cited by this paper
• NAMD2: Greater Scalability for Parallel Molecular Dynamics

  1999cited by this paper
• Dopamine receptors--physiological understanding to therapeutic intervention potential.

  1999cited by this paper
• Role of Conserved Serine Residues in the Interaction of Agonists with D3 Dopamine Receptors

  1999cited by this paper
• Distribution of Dopamine D3 Receptor Expressing Neurons in the Human Forebrain: Comparison with D2 Receptor Expressing Neurons

  1999cited by this paper
• Dopamine receptors: from structure to function.

  1998cited by this paper
• Contribution of serine residues to constitutive and agonist-induced signaling via the D2S dopamine receptor: evidence for multiple, agonist-specific active conformations.

  1998cited by this paper
• Mapping of dopamine D3 receptor binding site by pharmacological characterization of mutants expressed in CHO cells with the Semliki Forest virus system.

  1998influential reference
• Empirical scoring functions: I. The development of a fast empirical scoring function to estimate the binding affinity of ligands in receptor complexes

  1997cited by this paper
• Evaluation of comparative protein structure modeling by MODELLER‐3

  1997cited by this paper
• Biosynthesis, structure, and function of neuromelanin and its relation to Parkinson's disease: a critical update.

  1997cited by this paper
• Development and validation of a genetic algorithm for flexible docking.

  1997cited by this paper
• Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94

  1996influential reference
• CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice.

  1994cited by this paper
• Site-directed mutagenesis of the human dopamine D2 receptor.

  1992cited by this paper
• Contributions of Conserved Serine Residues to the Interactions of Ligands with Dopamine D2 Receptors

  1992cited by this paper
• CHARMM: A program for macromolecular energy, minimization, and dynamics calculations

  1983cited by this paper
• ITERATIVE PARTIAL EQUALIZATION OF ORBITAL ELECTRONEGATIVITY – A RAPID ACCESS TO ATOMIC CHARGES

  1980cited by this paper
• Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.

  1973cited by this paper

• Further exploration of N-4 substituents on the piperazine ring of the hybrid template 5/ 7-{[2-(4-Aryl-piperazin-1-yl)-ethyl]-propyl-amino}-5,6,7,8-tetrahydro-naphthalen-2-ol and its analog: development of an exceptionally potent agonist for D2 & D3 receptors

  2024cites this paper
• Approach to the specificity and selectivity between D2 and D3 receptors by mutagenesis and binding experiments part I: Expression and characterization of D2 and D3 receptor mutants

  2022cites this paper
• New class of benzothiophene morpholine analogues with high selectivity and affinity were designed and evaluated for anti‐drug addiction

  2022cites this paper
• Eckol as a Potential Therapeutic against Neurodegenerative Diseases Targeting Dopamine D3/D4 Receptors

  2019cites this paper
• Aminergic GPCR-Ligand Interactions: A Chemical and Structural Map of Receptor Mutation Data.

  2018cites this paper
• Design, synthesis and biological evaluation of bitopic arylpiperazine-hexahydro-pyrazinoquinolines as preferential dopamine D3 receptor ligands.

  2018cites this paper
• Current Therapeutic Molecules and Targets in Neurodegenerative Diseases Based on in silico Drug Design

  2018cites this paper
• Advances and challenges in the search for D2 and D3 dopamine receptor-selective compounds.

  2018cites this paper
• Design, synthesis, and biological evaluation of structurally constrained hybrid analogues containing ropinirole moiety as a novel class of potent and selective dopamine D3 receptor ligands

  2018cites this paper
• Development of 18F-labeled agonist radioligands for PET imaging of the high-affinity state of cerebral dopamine D2/3 receptors

  2017cites this paper
• A Molecular Basis for Selective Antagonist Destabilization of Dopamine D3 Receptor Quaternary Organization

  2017cites this paper
• Functional reversal of (−)‐Stepholidine analogues by replacement of benzazepine substructure using the ring‐expansion strategy

  2016cites this paper
• Two Binding Geometries for Risperidone in Dopamine D3 Receptors: Insights on the Fast-Off Mechanism through Docking, Quantum Biochemistry, and Molecular Dynamics Simulations.

  2016cites this paper
• Current drug treatments targeting dopamine D3 receptor.

  2016cites this paper
• Dopamine D3 agonists in the treatment of Parkinson's disease.

  2015cites this paper
• Efficacy of Hybrid Tetrahydrobenzo[d]thiazole Based Aryl Piperazines D-264 and D-301 at D2 and D3 Receptors

  2015cites this paper
• Identification of key residues involved in the activation and signaling properties of dopamine D3 receptor.

  2015cites this paper
• Structural Modifications of Neuroprotective Anti-Parkinsonian (−)-N6-(2-(4-(Biphenyl-4-yl)piperazin-1-yl)-ethyl)-N6-propyl-4,5,6,7-tetrahydrobenzo[d]thiazole-2,6-diamine (D-264): An Effort toward the Improvement of in Vivo Efficacy of the Parent Molecule

  2014cites this paper
• Understanding the Structural Requirements of Hybrid (S)-6-((2-(4-Phenylpiperazin-1-yl)ethyl)(propyl)amino)-5,6,7,8-tetrahydronaphthalen-1-ol and its Analogs as D2/D3 Receptor Ligands: A Three-Dimensional Quantitative Structure-Activity Relationship (3D QSAR) Investigation.

  2014cites this paper
• Synthesis and characterization of a novel series of agonist compounds as potential radiopharmaceuticals for imaging dopamine D₂/₃ receptors in their high-affinity state.

  2014cites this paper
• Antipsychotic haloperidol binding to the human dopamine D3 receptor: beyond docking through QM/MM refinement toward the design of improved schizophrenia medicines.

  2014cites this paper
• Dopamine D(3) receptor as a new pharmacological target for the treatment of depression.

  2013cites this paper
• Regulation of intraocular pressure in mice: structural analysis of dopaminergic and serotonergic systems in response to cabergoline.

  2013cites this paper
• Insights into the structural biology of G-protein coupled receptors impacts drug design for central nervous system neurodegenerative processes

  2013cites this paper
• Modification of agonist binding moiety in hybrid derivative 5/7-{[2-(4-aryl-piperazin-1-yl)-ethyl]-propyl-amino}-5,6,7,8-tetrahydro-naphthalen-1-ol/-2-amino versions: impact on functional activity and selectivity for dopamine D2/D3 receptors.

  2013cites this paper
• Quantum Biochemistry Description of the Human Dopamine D3 Receptor in Complex with the Selective Antagonist Eticlopride

  2012cites this paper
• Novel bivalent ligands for D2/D3 dopamine receptors: Significant co-operative gain in D2 affinity and potency.

  2012cites this paper
• Identification and Characterization of a Novel Class of Atypical Dopamine Receptor Agonists

  2012cites this paper
• Homology Modeling of Dopamine D2 and D3 Receptors: Molecular Dynamics Refinement and Docking Evaluation

  2012influential citation
• Novel computational biology methods and their applications to drug discovery

  2011cites this paper